Remote Programming of Cardiac Implantable Electronic Device

Status Completed

Clinical Trial Summary

Cardiac Implantable Electronic Devices (CIEDs) such as pacemakers and implantable cardioverter defibrillators, need to be regularly interrogated and reprogrammed to ensure proper functioning. While remote monitoring allows for partial interrogation at a remote location, full interrogation and changing the CIED parameters is only possible when the patient visits a cardiologist capable of performing device programming. This can be challenging for patients and may cause unnecessary delays, particularly in settings of limited resources, enforced physical distancing, and quarantines. We aim to investigate the efficacy and safety of remote programming.

Clinical Trial Description

Cardiac Implantable Electronic Devices (CIEDs) such as pacemakers and implantable cardioverter defibrillators, need to be regularly interrogated to guarantee proper functioning. In France, the follow-up of approximately 400 000 patients implanted with a CIED is performed by cardiologists. Remote monitoring allows for interrogation of contemporary CIEDs and has revolutionized the care for implanted patients. Early detection of arrhythmias, lead issues, battery depletion and algorithm side effects decreases both morbidity and mortality of CIED patients which is why today remote monitoring enjoys a class IA recommendation. While remote interrogation is advancing steadily, remote programming is not at all possible today. CIED problems may be quickly solved by changing the parameters but this is only possible when the patient visits a cardiologist capable of performing CIED programming. This can be challenging for patients and may cause unnecessary delays, particularly in settings of limited resources, enforced physical distancing, and quarantines. Remote programming of a CIED offers multiple advantages such as shorter travel distances for the patient, reduced need for presence of specialized cardiologists (in small clinics or diagnostic centers) and the possibility to offer expert support at remote locations or developing countries. At Bordeaux University, we have developed a method which enables remote programming of a CIED. The method requires the patient to be in direct vicinity of a CIED programmer, while the cardiologist specialized in CIED programming can operate the programmer from any remote location. We aim to investigate the efficacy and safety of remote programming by applying our method to implanted patients to perform remote interrogation and programming changes. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05366660
Study type	Interventional
Source	University Hospital, Bordeaux
Contact
Status	Completed
Phase	N/A
Start date	June 8, 2021
Completion date	April 4, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03574480` - Smartphone Applications to Improve Lifestyles in Olders Over 65 Years	N/A
Not yet recruiting	`NCT04070066` - Educational Strategy IN Exchange Transfusion	N/A
Active, not recruiting	`NCT05043220` - Covid-19 Predictors: Safety of Gynecological Oncology Patients Undergoing Systemic Cancer Therapy	N/A
Recruiting	`NCT04045054` - Home-based Transitional Telecare for Older Veterans	N/A
Completed	`NCT04652674` - Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic	N/A
Completed	`NCT03295474` - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Recruiting	`NCT05480930` - Improving Nighttime Access to Care and Treatment; Part 4-Haiti	N/A
Completed	`NCT02196428` - Medical Telemonitoring Plus Individual Teleconsultation in Elderly	N/A
Completed	`NCT03025217` - Total Lifestyle Coaching Pilot Study (TLC)	N/A
Completed	`NCT01820234` - Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event	N/A
Recruiting	`NCT04392518` - Telerehabilitation in Proximal Muscle Weakness	N/A
Completed	`NCT05147038` - The Impact of Tele-coaching on the Physical Activity Level	N/A
Not yet recruiting	`NCT05897710` - Virtual World-Based Cardiac Rehabilitation	N/A
Not yet recruiting	`NCT06466837` - Just-In-Time Adaptive Interventions for Diabetic Patients	N/A
Not yet recruiting	`NCT04444297` - 3D Telemedicine During COVID-19: Non-clinical Validation	N/A
Not yet recruiting	`NCT04513496` - Telemedicine in HIV Care in Buenos Aires
Completed	`NCT05895539` - Evaluating Treatment Continuation in Telehealth Patients Receiving an Automated Patient-Reported Outcome Tool	N/A
Active, not recruiting	`NCT03474692` - Virta Health Registry
Recruiting	`NCT05046392` - mHealth Facilitated Intervention to Improve Medication Adherence Among Persons Living With HIV	N/A
Recruiting	`NCT05231018` - A Study on a Digital Platform for COVID19+ Patients, Designed to Facilitate Communication and Mental-health Care During and After Hospitalization.	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Remote Programming of Cardiac Implantable Electronic Device — REACT

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms